🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Reliability and Validity of the Turkish Version of General Sleep Disturbance Scale (GSDS-T) in Multiple Sclerosis

Recruitingn/aAges 18 Years - 65 YearsAllIstanbul Medeniyet University
NCT06875908 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The GSDS-T was developed by Lee KA to assess difficulty falling asleep, waking up during sleep, sleep quality, and daytime alertnes. The Turkish validity and reliability of the scale have been conducted on stroke patients but not on multiple sclerosis patients. The aim of this study is to investigate the validity and reliability of the Turkish version of general sleep disturbance scale (GSDS-T) in patients with multiple sclerosis

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Individuals over the age of 18 who have been diagnosed with Multiple Sclerosis for at least two years, * Those with an EDSS score \>2. * Those without symptoms of insomnia according to the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) diagnostic criteria * Individuals whose native language is Turkish and who have the ability to speak and understand. Exclusion Criteria: * Those with severe spasticity, * Those with vision and hearing problems, * Those with a known mental illness (major depression, schizophrenia, psychosis, etc.), * Those in an acute relapse phase, * Those using dietary supplements, * Those using tranquilizers or immunosuppressants.
💊

What it tests

  • Turkish Validity and Reliability of The GSDS-T in patients with multiple sclerosis
📍

Where

1 site
Bağcılar Training and Research Hospital
Bağcılar, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy